Fresenius group in figures

in million € 2009 2008 2007 2006 2005
1 2008 before special items from the APP acquisition; 2009 adjusted for the effects of the mark-to-market accounting of the MEB and the CVR.
2 Net income attributable to Fresenius SE.
3 Equity including noncontrolling interest.
4 Investments in property, plant and equipment and intangible assets, acquisitions.
5 2005: balance sheet adjusted for acquisition of HELIOS Kliniken.
6 2006 pro forma Renal Care Group, excluding earnings from the divestiture of US dialysis clinics as well as their first quarter 2006 earnings.
7 2006 pro forma Renal Care Group, excluding first quarter 2006 earnings of divested US dialysis clinics.
8 Proposal
9 Adjusted for share split in February 2007.
10 2008 pro forma APP Pharmaceuticals and excluding special items from the APP-acquisition.
11 2009 adjusted for the effects of the mark-to-market accounting of the MEB and the CVR.
12 2005 pro forma HELIOS
Sales and Earnings          
Sales 14,164 12,336 11,358 10,777 7,889
EBIT 2,054 1,727 1 1,609 1,444 969
Net income 2 514 1 450 1 410 330 222
Depreciation and amortization 562 783 421 399 320
Earnings per ordinary share in € 3.18 1 2.85 1 2.64 2.15 9 1.76 9
Earnings per preference share in € 3.19 1 2.86 1 2.65 2.16 9 1.77 9
Cashflow and Balance sheet          
Operating cash flow 1,553 1,074 1,296 1,052 780
Operating cash flow in % of sales 11.0 % 8.7 % 11.4 % 9.8 % 9.9 %
Total assets 20,882 20,544 15,324 15,024 11,594
Non-current assets 15,519 15,466 11,033 10,918 8,063
Equity 3 7,652 6,943 6,059 5,728 5,130
Net debt 7,879 8,417 5,338 5,611 3,250
Net debt / EBITDA 6, 10 3.0 3.6 2.6 3.0 2.3 12
Equity ratio 3 37 % 34 % 40 % 38 % 44 %
Investments 4 931 4,617 1,318 4,314 2,247
Profitability          
EBIT margin 14.5 % 14.0 % 1 14.2 % 13.4 % 12.3 %
Return on equity after taxes (ROE) 5, 7, 10, 11 12.0 % 10.5 % 12.0 % 10.4 % 11.4 %
Return on operating assets (ROOA) 5, 6, 10 10.5 % 9.8 % 11.4 % 10.4 % 11.7 %
Return on invested capital (ROIC) 5, 6, 10 8.2 % 7.3 % 8.4 % 7.4 % 8.0 %
Dividend per ordinary share in € 0.75 8 0.70 0.66 0.57 0.49 9
Dividend per preference share in € 0.76 8 0.71 0.67 0.58 0.50 9
Employees (December 31) 130,510 122,217 114,181 104,872 91,971

in million € 2009 2008 2007 2006 2005
1 2008 before special items from the APP acquisition; 2009 adjusted for the effects of the mark-to-market accounting of the MEB and the CVR.
2 Net income attributable to Fresenius SE.
3 Equity including noncontrolling interest.
4 Investments in property, plant and equipment and intangible assets, acquisitions.
5 2005: balance sheet adjusted for acquisition of HELIOS Kliniken.
6 2006 pro forma Renal Care Group, excluding earnings from the divestiture of US dialysis clinics as well as their first quarter 2006 earnings.
7 2006 pro forma Renal Care Group, excluding first quarter 2006 earnings of divested US dialysis clinics.
8 Proposal
9 Adjusted for share split in February 2007.
10 2008 pro forma APP Pharmaceuticals and excluding special items from the APP-acquisition.
11 2009 adjusted for the effects of the mark-to-market accounting of the MEB and the CVR.
12 2005 pro forma HELIOS
Sales and Earnings          
Sales 14,164 12,336 11,358 10,777 7,889
EBIT 2,054 1,727 1 1,609 1,444 969
Net income 2 514 1 450 1 410 330 222
Depreciation and amortization 562 783 421 399 320
Earnings per ordinary share in € 3.18 1 2.85 1 2.64 2.15 9 1.76 9
Earnings per preference share in € 3.19 1 2.86 1 2.65 2.16 9 1.77 9
Cashflow and Balance sheet          
Operating cash flow 1,553 1,074 1,296 1,052 780
Operating cash flow in % of sales 11.0 % 8.7 % 11.4 % 9.8 % 9.9 %
Total assets 20,882 20,544 15,324 15,024 11,594
Non-current assets 15,519 15,466 11,033 10,918 8,063
Equity 3 7,652 6,943 6,059 5,728 5,130
Net debt 7,879 8,417 5,338 5,611 3,250
Net debt / EBITDA 6, 10 3.0 3.6 2.6 3.0 2.3 12
Equity ratio 3 37 % 34 % 40 % 38 % 44 %
Investments 4 931 4,617 1,318 4,314 2,247
Profitability          
EBIT margin 14.5 % 14.0 % 1 14.2 % 13.4 % 12.3 %
Return on equity after taxes (ROE) 5, 7, 10, 11 12.0 % 10.5 % 12.0 % 10.4 % 11.4 %
Return on operating assets (ROOA) 5, 6, 10 10.5 % 9.8 % 11.4 % 10.4 % 11.7 %
Return on invested capital (ROIC) 5, 6, 10 8.2 % 7.3 % 8.4 % 7.4 % 8.0 %
Dividend per ordinary share in € 0.75 8 0.70 0.66 0.57 0.49 9
Dividend per preference share in € 0.76 8 0.71 0.67 0.58 0.50 9
Employees (December 31) 130,510 122,217 114,181 104,872 91,971

Continue reading:
To our shareholders

QUICKFINDER